BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (NASDAQ: ARRY) today announced the appointment of Jonathan Kay, M.D., to its Scientific Advisory Board. Dr. Kay will work with the Array team to facilitate the development of its inflammation portfolio.
